There are many barriers to diabetes care. This paper explores whether organising these barriers to Type 2 diabetes care within the clinical framework of patient-centred medicine (PCM) enables a better appreciation and conceptualisation of these barriers. The terms 'diabetes', 'barriers to care', 'self-management', 'patient-centred care' and 'outcome assessment' were used to identify 28 articles describing multiple barriers (minimum of three) to care in Type 2 diabetes. Identified barriers were organised within the clinical framework of PCM. Barriers to diabetes care were numerous and diverse, but all could be accommodated within the PCM framework, except for one, that of patient non-compliance (non-adherence). This paternalistic concept contradicts patient autonomy, a key component of the PCM paradigm.
Introduction
Many people with diabetes have poor glycaemic control despite both patients and providers knowing that tight control minimises complications. 1 A wide range of barriers to diabetes care have been described, [2] [3] [4] [5] including patient noncompliance (non-adherence). 2, [4] [5] [6] [7] [8] To overcome compliance barriers, emphasis has been placed on the need to educate patients to ensure that they follow recommended lifestyle changes and take medications as prescribed. 8 However, attempts to improve non-compliance have had little impact on long-term glucose control. 7, 8 Why patients don't comply with expert recommendations remains an anomaly of the biomedical paradigm.
'Patient-centredness', as a construct, is generally agreed to be important. 9, 10 In this paper, we examine whether organising barriers to diabetes care within the patient-centred medicine (PCM) 11 clinical framework enables a better appreciation and conceptualisation of the range of barriers to care faced by people with Type 2 diabetes, and how this approach may assist clinicians to more fully explore these barriers with their patients.
Looking to the literature
A search of Medline, the Cochrane Library, the authors' personal reference collections, and the bibliographies of relevant papers was made to find both qualitative and quantitative research articles identifying at least three barriers to care for people with Type 2 diabetes. The Medline and Cochrane Library websites were searched twice: first using the terms 'diabetes', 'barriers to care', and 'self-management', and second using the terms 'patient-centered care', 'outcome assessment', and 'diabetes'. Review articles of barriers to diabetes care were excluded. Both authors independently evaluated the papers for inclusion, and independently extracted the barriers to diabetes care. A total of 28 articles met our inclusion criteria and formed the dataset for this paper. Any disagreements were resolved by consensus. Barriers were organised under the headings (I-VI) and subheadings (a, b, c etc.) of the PCM clinical framework (see Table 1 ).
Identified barriers to care
Identified barriers to care for people with Type 2 diabetes are presented in this section of the paper under the headings and subheadings of PCM (Table 1) . 11 There was only one barrier that did not fit within the PCM framework: 'patient noncompliance'. This barrier was identified in 12 of the 28 articles. 12, 13, 16, 20, 21, [27] [28] [29] [30] 32, 35, 36 I. Disease and illness experience a) Fears/feelings as barriers to self-management i. Fear or distress: The identified fear could be non-specific, such as fear of loss of control over their life, [14] [15] [16] [17] [18] [19] 37 or of potential future events (disease complications, 14, [22] [23] [24] and drug side effects 16, 19, 20, 25, 35, 39 ). The fear could also be specific to events, such as glucose monitoring, 19, 20, 36 diagnosis, 18, 21, 22, 24, 29, 37 starting oral medications, 16, 18, 19, 36 starting insulin (including fear of insulin and needles), 16, [18] [19] [20] [21] 35, 36, 39 and fear of hypoglycaemia. 13, 16, 19 ii. Despair as a barrier: Feelings of despair were identified as a barrier to care in a number of studies. 14, 18, 19, 21, 23, 24, 34, 39 iii. Guilt/self-blame: Patients frequently blamed themselves for poor diet/lifestyle as the cause of their diabetes and its poor control. 13, 15, 17, 19, 20, 34, 39 iv. Shame/embarrassment/ stigma: Understanding the disease requires history, examination, and investigation.
Understanding the illness experience requires an exploration of four dimensions.
a) Feelings/fears
The emotional/psychological responses to the illness.
b) Ideas/beliefs
The intellectual response to the illness.
c) Effects on functioning
The impact of the illness on body and lifestyle.
d) Expectations
What the person expects of the clinician.
II. Understanding the whole person
The meaning of health and illness to a person varies according to their context. Just as the body is made up of a number of interlocking systems, so too the individual is a part of a family, a community, a culture, a country and an ecology. Clinical information only becomes useful knowledge when it is placed in the context of a particular patient's world. Ignoring context will lead to errors in both the interpretation and application of findings. Culture, health care system, community, economics.
III. Finding common ground
The process through which the patient and clinician reach mutual understanding and agreement in three key areas. specific beliefs, such as diabetes is caused by eating sugar, 15, 19, 23, 36 a strict diet is required to control/cure diabetes, 18, 19, 36 only people with diabetes need to eat a healthy diet, 18, 19, 36, 39 diabetes is like a 'cold' (it will just go away if ignored), 14, 15, [17] [18] [19] 23, 27, 29, 35, 36 diabetes is the same for everyone, 19, 24 resignation to the diagnosis of diabetes, 15, 23, 24, 29 symptoms as motivators (if there are no symptoms, then there is no need to take action), 15, 18, 19, 21, 23, 29, 32, 33, 35, 36, 39 diabetes is 'uncontrollable' (trouble coping), 15, 20, 31, 34, 39 they only need to take insulin if blood glucose is high, 35 and diabetes seen as a punishment. 15 ii. Cultural beliefs: There were both overly positive and negative beliefs about modern health care that could act as barriers, 15, 17, 28, 29, 36, 39 such as 'Western drugs' are chemicals to be avoided, 17, 19, 36, 39 and modern 'Western medicine' will do everything (there is no need to make lifestyle changes). 17, 24, 27, 29 Specific cultural beliefs as barriers have been described for Māori, 19 Bangladeshi, 23 South Asian, 24 Samoan, 18 Korean, 30 and Cambodian 36 people.
c) Effects on functioning
i. Disease-imposed barriers: These included resentment of the routine imposed by diabetes, 13,14,16-21 medication side effects that restrict your life, 19 impact on the family (including separate meals), 19, 21 and imposed dietary change. 28, 30, 34, 36 ii. Disabilities as barriers: Disabilities included diabetes-related complications (e.g. amputation and blindness), 17, 29, 39 non-diabetes related physical disabilities, 17, 24, 26, 29, 30, 37, 39 and mental health disabilities (e.g. depression and alcoholism). 16, 24, 30, 34, 37 d) Expectations i. Communication barriers: Besides poor communication in general, 12, 13, 17, 19, 22, 27, 34, 36, 39 use of jargon 19, 22, 24 and little knowledge transfer to the patient, 14, 17, 19, 21, 22, 24, 28, 31, 34, 35 were specifically identified.
ii. Time barriers: Short consultations due to time pressure. 14, 17, 19, 23, 28, 29, [33] [34] [35] [36] iii. Relationship barriers: Barriers included patients being too deferential 24, 35, 36 or even not trusting their clinician; 18, 22, 27, 36 and clinicians being judgmental, 19, 27, 32 and having unrealistic expectations of patients. 34 
II. Understanding the whole person a) Person
i. Personality barriers: Diabetes selfmanagement may be more difficult for some people, such as those with an 'external locus of control', described as passive, dependent, having low self-efficacy and being more reliant on others. 14, 17, 22, 29, 39 ii. Gender barriers: Males were described as poor attendees, 28, 30, 32 and South-east Asian females in one study indicated they would like gender-specific education sessions. 24 iii. Biopsychosocial barriers: Some patients have complex health needs, which make diabetes care more challenging.
b) Proximal context
i. Family barriers: These included other family members being given priority, 15, 17, 19, 30, 39 and the family being unsupportive. 13, 17, 18, 21, 26, 37, 39 ii. Financial barriers: These included costs related to clinician visits and drugs, 12, 17, 19, [25] [26] [27] [28] [29] 31, 32, 35, 39 'healthy' foods, 13, 19, 23, 26, 29 travel to access care, 28, 33, 39 group education sessions, 31,33 time away from work to attend appointments, 28 as well as fluctuating personal financial situations. 19, 28 iii. Education/health literacy barriers:
These included poor literacy/ education, 12, [16] [17] [18] [19] [21] [22] [23] 25, 27, 28, 32, 33, [35] [36] [37] 39 lack of diabetes self-management education, 30, 37, 38 and that knowledge is not sustained over time. 14, 21 iv. Employment barriers: These related to insulin use, including inflexibility around breaks and meals with shift work, 19 ,21 lack of privacy to give injections, 19 missing doses to avoid hypoglycaemia with physically demanding jobs, 19 and declining insulin as a treatment option because they drove for a living. 21 v. Leisure barriers: These included restricting exercise because of the fear of exercise causing hypoglycaemia 19 (see also section Ia-i. Fear or distress ) and the inconvenience of always having to plan ahead. 19 vi. Social support barriers: These included the public stigma of injecting insulin (see also sections Ia-iv and IIb-iv), being 'bullied' about food choices, 19, 21 and being socially isolated. 19, 21, 27, 37, 38 c) Distal context i. Cultural differences as barriers:
These include cultural beliefs (see section Ib-ii), inappropriate cultural messages, 17, 39 cross-cultural gaps (including language differences) between patient and clinician, 13, [22] [23] [24] [25] 29, 32, [34] [35] [36] 39 and that participating in sports as exercise may have no cultural meaning. 23, 35, 36 ii. Health care system barriers: These include a poor knowledge of available health care services, 17,31,32,39 difficulty accessing health care services (such as lack of a public bus service), 17 28 long waiting times for secondary care, 28 diabetes care being a low priority to funders, 17, 33 lack of clinical recall systems, 29, 33 poor remuneration for chronic disease management, 33, 38 and inadequate patient education. 27, 29, 33, 38 iii. Community barriers: These include a lack of public transport, 17 lack of healthy food availability, 17, 39 and unsafe streets for walking as exercise. Additional barriers include clinicians not asking about patients' decision-making processes, 22, 27 and inappropriate use of external motivators (e.g. trying to 'shock' the patient with the fear of complications) to motivate patients. 22, 33, 34, 38 (also see sections Id-i and Va-iii) and may be unaware of how social and cultural gaps between the patient and clinician can impact on care. 13, 22, 32 ii. Clinician emotional responses as barriers: These relate to either lack of clinician motivation due to perceived lack of respect, 27, 28 or to clinician frustration and anger impacting on the relationship due to perceived patient non-compliance. 
Implications for practice
To the authors' knowledge, this is the first paper to use the PCM clinical framework (Table 1) 11 to illustrate the wide range of barriers to care for people with Type 2 diabetes. Not only does this help clinicians appreciate the large number of potential barriers faced by their patients with Type 2 diabetes, but it also provides a practical framework within which to examine these barriers in the clinical setting.
Medical training focuses on diagnosing and managing disease, with less emphasis placed on understanding the illness experience of patients, now recognised as an integral component of successful chronic disease management. 10 However, all clinicians need to be aware of, and to explore, the emotional responses patients may have to their diabetes (such as distress or fear [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] ). Similarly, all clinicians need to be aware of, and to explore, patients' poor understanding of diabetes [14] [15] [16] [17] [18] [19] and non-scientific beliefs about their diabetes (such as diabetes is caused by eating sugar, 15, 19, 23, 36 diabetes is an acute illness that will resolve, 14, 15, [17] [18] [19] 23, 27, 29, 35, 36 no symptoms means no disease 15, 18, 19, 21, 23, 29, 32, 33 ). These may negatively impact on patient self-management if not explored and discussed.
PCM
11 provides a clinical framework to enable all clinicians to explore barriers to care. Investigating both the disease and illness experience (see Table 1 , section I) requires the clinician to understand the disease process, as well as the need to work with each patient's unique illness experience. Clinicians focusing only on diabetes disease management ignores the significant impact that a person's feelings, beliefs and expectations about their illness will have on their self-management. Section II: Understanding the whole person further expands a clinician's understanding of the patient's illness experience by providing the context of the patient's life experience, such as educational, financial, and family/work constraints and the impact they may have on diabetes self-management. Similarly, Section III: Finding common ground requires the clinician to establish trust and respect within the therapeutic relationship, so that mutual understanding and agreement can be reached regarding problem definition, goals of treatment, and respective roles. Section IV: Incorporating disease prevention and health promotion reminds the clinician to broaden the discussion beyond diabetes control. Section V: Enhancing the clinician-patient relationship can also be viewed as a reminder to clinicians that every encounter is an opportunity to build on their relationship with a patient; while Section VI: Being realistic reminds the clinician to be aware of their own limitations, as well as those of their patients and the health care system. Being realistic may help to provide a better appreciation of, and focus on, those barriers that can be changed.
By following these six interactive components of the patient-centred process, the clinician and patient can together explore and identify what is truly meaningful for that patient, so that glycaemic control becomes as much a patient priority, as a clinician priority. Table 2 presents some questions from a PCM perspective that could assist health care providers to more fully explore each patient's barriers to diabetes self-management.
All of the barriers related to the first and third components of PCM (Section I. Disease and illness experience and Section III. Finding common ground; see Table 1 ) can be explored, understood and/or potentially rectified from within the clinician-patient relationship. Likewise, many barriers in the second component (Section II. Understanding the whole person) can be resolved by clinicians working in partnership with their patients (e.g. always including costs when discussing the range of management options so that patients can decide how best to spend their money). Obviously, resolution of some barriers requires the effort of people and agencies outside the clinical team (e.g. lack of ramps into clinics, no after-hours clinics, lack of privacy at workplaces for injecting insulin, social stigma regarding injecting insulin). However, it is entirely within the clinicians' ability to explore the impact of these barriers on individual patients. Furthermore, the onus is clearly on the clinician with regard to overcoming paternalistic attitudes that deny patients their autonomy in decisionmaking. As pointed out by Rodriguez, 'I may know what is best for another person's health, but I am ignorant and arrogant if I think I know what is best for another person's life.' 40 Within the 28 papers identified by the authors describing three or more barriers to diabetes care, there was only one barrier that did not fit within the PCM framework-that of 'patient non-compliance' (non-adherence). PCM recognises patients as autonomous beings, experts of their own lives, who make the best decisions they can with the knowledge they possess. There is no expectation that they will simply passively comply with expert recommendations and, as such, within PCM the concept of non-compliance is irrelevant. 41 Indeed, the clinician belief in noncompliance is, in fact, the barrier that needs to be addressed.
Accepting patient 'non-compliance' as an explanation for poor diabetes control allows clinicians to simply attribute blame to the patient, 32 and prevents providers from exploring and determining the real barriers to care. The clinician remains ignorant of why their patient has decided to disregard their recommendations, and misses the opportunity to work alongside their patient to identify which of the many barriers are preventing that person from having better diabetes control. Simply attributing blame to patients for perceived non-compliance shows a lack of respect for that person's choices, interferes with the establishment of a therapeutic partnership, and prevents the clinician from becoming a positive change enabler that empowers their patient to self-manage their diabetes. 42 This critical blindspot of the biomedical paradigm has been repeatedly identified as a significant barrier to patient self-management. 4, 14, 23, 27, 31, 41, 43, 44 Informed consent, 45 like patient-centred medicine, recognises that most clinical interventions involve choice and that an autonomous patient may have very specific reasons for selecting their preferred management option. It also recognises that patients will only succeed in choosing what is the best option for themselves if they are truly well-informed. Thus, to ensure consent is freely given by an informed, competent patient, clinicians are required to provide the information about all treatment options, including the option of no treatment. 45 This puts the onus on the clinician to communicate effectively.
To date, diabetes management has frequently not met this standard. Some clinicians simply choose what they think is the best treatment for their patient (i.e. no patient choice), or patients may be told only about some treatment options (e.g. only those recommended by disease management guidelines or those that the clinician thinks are best or affordable for the patient). Until recently, diabetes management guidelines have ranked management choices based on the best available evidence, with the goal of producing desirable Explore depression, dementia, and other psychiatric diagnoses.
b) Proximal context
Do any of the following affect your ability to care for your diabetes: your family, your finances, your job, your hobbies, or your socialising?
Explore family views about diabetes; current financial problems; difficulties giving insulin at work.
Explore their health literacy: can they read, is English their second language? c) Distal context Do you feel any of the following affect your ability to care for your diabetes: your culture, the health care system, or your local community?
Explore cultural beliefs about diabetes and treatment; barriers in accessing health care; barriers in the community.
Finding common ground Make explicit
As a clinician, my goal is to work in partnership with my patients to help them in whatever way I can to control their diabetes and stay healthy. However, while I may be a disease expert and know a lot about diabetes, you are the expert of your life, and how diabetes and its treatment fits into your life. So we need to agree together on three important areas: a) What do you believe is keeping you from being able to control your diabetes? Of these, what do you think are the top priorities?
b) What would you like to achieve with your diabetes management? What are your specific goals and how will we know when we have been successful? c) What do we each need to do to achieve these goals?
Teach back
For you, what has been the most important things we've discussed today, and how will you explain them to your family?
Final comments
Using the PCM clinical framework to identify barriers to care in Type 2 diabetes not only allows a better appreciation of the large range of potential barriers, but also provides a practical framework with which to explore these barriers with patients. Behavioural change is difficult, but patients may become better self-managers of their diabetes when clinicians shift from a directive, paternalistic approach ('Do what I say'), to a collaborative, respectful partnership, where they jointly identify and attempt to eliminate or minimise barriers. This collaborative approach also eliminates the clinician barrier of labelling patients as non-compliant, which effectively prevents clinicians from exploring the real barriers to care. Clinicians will undoubtedly discover just how difficult behavioural change is, once they see that it is they themselves, not their patients, who really need to change.
disease-oriented outcomes. However, recognising patient participation as key to successful diabetes management, the 2012 consensus guideline from the American Diabetes Association and the European Association for the Study of Diabetes acknowledges that there is little evidence to support one treatment option over another for HbA1c reduction, and that patient participation in medical decision-making 'constitutes one of the core principles of evidence-based medicine'. 10 Accordingly, these guidelines have been written to fully inform clinicians of all available treatment options so that they can 'integrate current evidence with other constraints and imperatives in the context of patient-specific factors'.
10
To adopt a patient-centred approach, clinicians need to eliminate the terms non-compliance/ non-adherence from their vocabulary, and instead embrace a respectful curiosity about why patients make certain decisions, that to some providers may seem like 'wrong' decisions. Thus, successful disease outcomes will depend more on clinicians changing their approach to diabetes management, than on patients changing.
Patient-centred care has been included as one of the six core attributes of a quality health care system by the Institute of Medicine in the United States. 9 The patient-centred paradigm combines the best of biomedical and social science research, and applies it to the human interaction that is patient care. The patient-centred paradigm has subsumed the biomedical paradigm, by borrowing theory and research findings from the social sciences 44 to account for the anomaly of non-compliance. Changing paradigms within science is difficult, and sometimes scientists and clinicians never change. As Max Planck said:
A new scientific truth does not triumph by convincing its opponents and making them see the light, but rather because its opponents eventually die, and a new generation grows up that is familiar with it. 46 Hospital-based clinicians may find the change particularly challenging, as the expanded theoretical framework embraces social sciences research and methodologies 44 with which many will be unfamiliar, and was introduced into medicine by family doctors who are frequently not highly regarded within the medical power hierarchy.
